Development of a therapeutic approach to rare cancers in children: The children's oncology group experience

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue SUPPL. 2, 2012, Pages

  Pashankar, Farzana D ^a   Rodriguez Galindo, Carlos ^b   Pappo, Alberto ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

children; Children's Oncology group; Rare cancers

Indexed keywords

ADRENAL CORTEX CARCINOMA; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CARCINOID; CHILDHOOD CANCER; COLORECTAL CARCINOMA; DICER 1 GENE; GASTROINTESTINAL STROMAL TUMOR; GENE; GENE MUTATION; HETEROZYGOSITY; LUNG BLASTOMA; MELANOMA; NASOPHARYNX CARCINOMA; PLEUROPULMONARY BLASTOMA; PRIORITY JOURNAL; RARE DISEASE; RARE TUMOR; SEX CORD TUMOR; THYROID CARCINOMA; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; RARE DISEASES;

EID: 84860289124     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31824e378e     Document Type: Article

References (9)

1. Smith M, Gloeckler Ries L. Childhood Cancer: Incidence, Survival and Mortality. Principles and Practice of Pediatric Oncology. 4th ed. Lippincott Williams and Wilkins: Philadelphia; 2002
2. National Institutes of Health. Office of Rare Disease Research. Rare Diseases and Related Terms. Available at: http://rarediseases. info.nih.gov/RareDiseaseList.aspx.
3. The European Parliament and the Council of Europe. Regulation (EC) No. 141/2000 of the European Parliament and of the Council of Europe of December 16,1999 on orphan medical products. Official Journal of the European Communities. 1999.
4. Ferrari A, Bisogno G, De Salvo GL, et al. The challenge ofvery rare tumors in childhood: the Italian TREP project. Eur J Cancer. 2007;43:654-659. (Pubitemid 46502898)
5. Bernstein L, Gurney J. Carcinomas and Other Malignant Epithelial Neoplasms, ICCC XI. National Cancer Institute, SEER Pediatric Monograph. Bethesda, MD; 1975-1995:139-147.
6. Pappo AS, Krailo M, Chen Z, et al. Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans. J Clin Oncol. 2010;28:5011-5016.
7. Hill DA, Ivanovich J, Priest JR, et al. DICER 1 mutations in familial pleuropulmonary blastoma. Science. 2009;325:965.
8. Ribeiro RC, Sandrini F, Figueiredo B, et al. An inherited p53 mutation that contributes in a tissue specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci. 2001;98: 9330-9335. (Pubitemid 32743916)
9. Brecht B, Graf N, von Schweinitz D, et al. Networking for children and adolescents with very rare tumors: foundation of the GPOH pediatric rare tumor group. Klin Padiatr. 2009;221: 181-185.